BRCA2 and breast carcinoma: &lt;i&gt;BRCA2&lt;/i&gt; Reversion Mutation after Neoadjuvant Dose-Dense EC and Dose-Dense Paclitaxel in Triple-Negative Breast Cancer: A Case Report and Literature Review.